5
Views
7
CrossRef citations to date
0
Altmetric
Original Article

A double-blind controlled trial of the selective serotonin uptake inhibitor femoxetine and amitriptyline in depression

, &
Pages 335-339 | Published online: 12 Jul 2009

References

  • Ahlberg B, Palm O, Honoré le Fevre P. En dobbelt-blind undersøgelse af femoxetin og arnitriptylin ved behandlingen af patienter med depressive tilstande. 1982, Personal communication
  • Bech P, Allerup P, Gram L F., Reisby B, Rosenberg R, Jacobsen O, Nagy A. The Hamilton depression scale Evaluation of objectivity using logistic models. Acta Psychiat Scand 1981; 63: 290–299
  • Buus Lassen J, Squires R F., Christensen J A., Molander L. a Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG 4963, with potential antidepressant properties. Psychopharmacologia (Berl) 1975; 42: 21–26
  • Buus Lassen J, Petersen E, Kjellberg B, Olsson S O. b Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymoleptics. Europ J Pharmacol 1975; 32: 108–115
  • Bøjholm S, Børup C, Kvist J, Petersen I-M, Honoré le Fevre P. A double-blind study of femoxetine and amitriptyline in patients with endogenous depression. Nord psykiat T 1979; 33: 455–460
  • Dahl L-E, Lundin L, Honoré le Fevre P, Dencker S J. Antidepressant effect of femoxe'ine and desipramine and relationship to the concentration of amine metabolites in the cerebrospinal fluid. Acta Psychiat Scand 1982; 66: 9–17
  • Ghose K, Gupta R, Coppen A, Lund J. Antidepressant evaluation and the pharmacological actions of FG 4963 in depressive patients. Europ J Pharmacol 1977; 42: 31–37
  • Gurney C, Roth M, Garside R F., Kerr T A., Schapira K. Studies in the classification of effective disorders The relationship between anxiety states and depressive illnesses-II. Brit J Psychiat 1972; 121: 162–166
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiat 1960; 23: 56–62
  • Reebye P N., Yiptong C, Samsoon J, Schulsinger F, Fabricius J. A controlled double blind study of femoxetine and amitriptyline in patients with endogenous depression. Pharmacopsychiat 1982; 15: 164–169

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.